Comments on: “Is the Risk Difference Really a More Heterogeneous Measure?” by Schmidt, AFF et al.
With great interest did we read the much needed commentary by Poole, Shrier, and 
VanderWeele1 on the empirical evidence behind claims that the risk difference is more 
heterogeneous than the odds ratio (i.e., the difference in effects between studies or groups of 
patients). In their contribution the authors show that the previously reported higher rejection 
rates of risk difference homogeneity may be explained by differences in power between 
measurement scales, an issue we previously addressed as well2. Without detracting from their 
contribution or conclusions, with which we agree, we were surprised that the authors omitted the 
theoretical grounds why the odds ratio is thought to be a less heterogeneous measure. 
 
Essentially, our comment is that the odds ratio (OR) can be homogeneous given any 
conceivable distribution of risk in patient subgroups, while the risk ratio (RR) and risk difference 
(RD) cannot. Take, for example, the hypothetical study mentioned by Poole et al., where the 
average risk in the control group was 0.27, and the average risk in the treated group 0.46 
(scenario1), resulting in an OR of 2.30, a RR of 1.70, and a RD of 0.19. If we now think it 
acceptable that the risk for any subgroup of control subjects is only bounded by 0 and 1, given 
the RD of 0.19, there cannot be any subgroup of control subjects with a risk higher than 0.81 
unless the RD is heterogeneous. In general the RD can be homogenous if the control group risk 
is bounded between max(0, 0-RD) and min(1-RD, 1). Similarly, for the RR to be homogenous, 
the risk in any subgroup of control subjects should be bounded between 0/RR and 1/RR, for the 
current example 0 and 0.59. The OR, however, can be homogeneous for any control group risk 
between 0 and 1. Given that the OR never “forces” heterogeneity, one might expect the OR to 
be the least heterogeneous in empirical settings as well. However, one may question whether 
these bounds are actually violated often in empirical settings; therefore we agree with Poole et 
al. that there is insufficient empirical evidence to claim any effect measure induced 
heterogeneity, and furthermore that comparisons between scales are difficult. In the end, sound 
biological reasoning on potential pathways may provide the most suitable grounds for choosing 
an effect measure, not mathematical or statistical properties. However, to facilitate such a 
choice, knowledge of these properties is, we feel, essential.  
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